Search
Investors
Tavotek is funded by leading biotech investors that believe in the world-changing, next generation approach of our platforms and cancer treatments.
Over $75 million has been raised in Series A and B funding since the company’s inception. The establishment of these long-lasting relationships have been a driving force in our growth.
727 Norristown Road, 3 Spring House Innovation Park Suite 101, Lower Gwynedd, Pennsylvania 19002
China. Suzhou. Suzhou Industrial Park. Unit 405, Building C2, No. 218, Xinghu Street
© 2023 Tavotek Biotherapeutics All rights reserved. (267) 405-9426
© 2023 Tavotek Biotherapeutics All rights reserved.(267) 405-9426